The total value of cross-border mega-merger deals so far this year has already exceeded 2017 levels, according to data compiled by Bloomberg Law.
Acquirers announced 14 cross-border deals valued above $10 billion totaling $315 billion during the first half of 2018, already surpassing last year’s $274.8 billion. The biggest transactions include Takeda Pharmaceuticals Co. Ltd.’s $80.2 billion bid for Shire PLC.
If the trend continues, the aggregate value of mega-deals could beat 2016’s $454.3 billion total, which was the highest since at least 2010, according to Bloomberg Law’s Quarterly Cross-Border M&A Market Update.
“We’re in a deal-friendly environment when you ...